TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3742458

Group type: EXPERIMENTAL
Intervention: Immunotherapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Dukes' stage
Number of subjects: 100

Group type: COMPARATOR
Intervention: Exophytic tumors
Number of subjects: 100

Group type: COMPARATOR
Intervention: Maximal tumor dimension
Number of subjects: 100

Group type: COMPARATOR
Intervention: Degree of differentiation (well vs poor)
Number of subjects: 100
Study: 29738588

Group type: EXPERIMENTAL
Intervention: Femtosecond laser CCIs
Number of subjects: 600

Group type: COMPARATOR
Intervention: Manual CCIs
Number of subjects: 600
Study: 27281813

Group type: EXPERIMENTAL
Intervention: 10 g fiber/d from SCF
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 20 g fiber/d from SCF
Number of subjects: 28

Group type: COMPARATOR
Intervention: 0 g fiber/d from SCF (Control)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Calcium absorption
Number of subjects: 28
Study: 24698652

Group type: EXPERIMENTAL
Intervention: Topical diclofenac 0.1% drop, one drop 2h preoperatively and four times daily postoperatively for 3 days
Number of subjects: 68

Group type: COMPARATOR
Intervention: Artificial tears (control group)
Number of subjects: 68
Study: 22161746

Group type: EXPERIMENTAL
Intervention: Multidisciplinary lifestyle treatment (medical, nutritional, physical, and psychological counseling during 3 months)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard care (initial advice on nutrition and physical activity by the pediatrician)
Number of subjects: 40
Study: 20530957

Group type: EXPERIMENTAL
Intervention: Ivanissevich technique
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Tauber's technique
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Subinguinal sclerotherapy
Number of subjects: 155
Study: 19164819

Group type: EXPERIMENTAL
Intervention: 20-week supervised physical activity program including aerobic, balance, and strength training
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 49
Study: 15265352

Group type: EXPERIMENTAL
Intervention: New drugs and treatments for cancer pain management
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomised controlled trials (RCT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Crossover study
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cohort studies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Case-control studies
Number of subjects: 0
Study: 11372012

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8525
Study: 9136958

Group type: EXPERIMENTAL
Intervention: C-VAMP (vincristine, doxorubicin, methylprednisolone, and cyclophosphamide)
Number of subjects: 204

Group type: COMPARATOR
Intervention: VAMP (vincristine, doxorubicin, and methylprednisolone)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: C-VAMP with verapamil
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Overall group (C-VAMP and VAMP)
Number of subjects: 204
Study: 8009094

Group type: EXPERIMENTAL
Intervention: High perception of illness threat
Number of subjects: 1982
Study: 3068936

Group type: EXPERIMENTAL
Intervention: Heparin DHE
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Moderate normovolaemic haemodilution (haematocrit = 30%)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 62
Study: 31315420

Group type: EXPERIMENTAL
Intervention: One-week (10-contact-hour), small-group, cervical health literacy (CHL) program
Number of subjects: 133
Study: 29634749

Group type: EXPERIMENTAL
Intervention: Chronic non-specific low back pain (CNLBP) patients
Number of subjects: 24

Group type: COMPARATOR
Intervention: Symptom-free controls (CG)
Number of subjects: 24
Study: 27038614

Group type: EXPERIMENTAL
Intervention: ACERTO protocol (n = 15): 6 h preoperative fasting for solids, oral drink (200 mL of 12.5% maltodextrin) up to 2 h before anesthesia, restricted intravenous fluids (1000 mL of crystalloid fluid after surgery), preoperative immune nutrition (600 mL/day of Impact - Nestlé, Brazil) for five days prior to surgery
Number of subjects: 32

Group type: COMPARATOR
Intervention: Traditional care (n = 17; control group): 6-8 h preoperative fasting, intravenous hydration until the 1st postoperative day, no preoperative immune supplementation
Number of subjects: 32
Study: 25627292

Group type: EXPERIMENTAL
Intervention: Evidence‐based program delivered in three 12‐week sessions including exercise and project‐based activities, done as individuals and in groups.
Number of subjects: 186
Study: 23547084

Group type: EXPERIMENTAL
Intervention: Ever smokers
Number of subjects: 1968

Group type: EXPERIMENTAL
Intervention: Ever smokers with BRAF wild-type
Number of subjects: 1968

Group type: EXPERIMENTAL
Intervention: Ever smokers with KRAS mutated
Number of subjects: 1968

Group type: EXPERIMENTAL
Intervention: Ever smokers with KRAS wild-type
Number of subjects: 1968

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 1968
Study: 20878857

Group type: EXPERIMENTAL
Intervention: Meaning-Making intervention (MMi)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study: 18338177

Group type: EXPERIMENTAL
Intervention: Subtotal hysterectomy
Number of subjects: 105

Group type: COMPARATOR
Intervention: Total hysterectomy
Number of subjects: 105
Study: 16377115

Group type: EXPERIMENTAL
Intervention: Simvastatin (SIM)
Number of subjects: 0
Study: 12816726

Group type: EXPERIMENTAL
Intervention: Single-expert review
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Consensus review
Number of subjects: 172

Group type: COMPARATOR
Intervention: Institutionally diagnosed cohort
Number of subjects: 172

Group type: COMPARATOR
Intervention: Overall cohort
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Resection extent, proliferation index, and p53 expression
Number of subjects: 172

Group type: COMPARATOR
Intervention: Different review criteria for each arm
Number of subjects: 172
Study: 10923604

Group type: EXPERIMENTAL
Intervention: Ketotifen, 1 mg twice a day
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 8736463

Group type: EXPERIMENTAL
Intervention: Antidepressant treatment (specifics not provided)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Nonresponders (no treatment specified)
Number of subjects: 63
Study: 1349301

Group type: EXPERIMENTAL
Intervention: 0.4 mg LHRH nasal spray three times daily for 4 weeks
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: 0.4 mg LHRH nasal spray
Number of subjects: 123
Study: 3933893

Group type: EXPERIMENTAL
Intervention: Indomethacin 25 mg three times daily
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Sulindac 200 mg twice daily
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Sulindac
Number of subjects: 26
Study: 30054187

Group type: EXPERIMENTAL
Intervention: Nicorandil
Number of subjects: 56

Group type: COMPARATOR
Intervention: Nitroglycerin
Number of subjects: 56
Study: 30193810

Group type: EXPERIMENTAL
Intervention: Virtual reality group (Xbox Kinect game system for 30 minutes per day)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (Conventional therapy for upper extremity for 60 minutes, 5 times per week for 4 weeks)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Virtual reality group
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 35
Study: 26920144

Group type: EXPERIMENTAL
Intervention: Ultrasonography-computed tomography fusion imaging
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional ultrasonography
Number of subjects: 20
Study: 25254207

Group type: EXPERIMENTAL
Intervention: Thai massage (TM)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Thai herbal compression (THC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oral ibuprofen
Number of subjects: 60
Study: 22364818

Group type: EXPERIMENTAL
Intervention: ethinylestradiol/desogestrel
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: ethinylestradiol/cyproterone acetate
Number of subjects: 450

Group type: COMPARATOR
Intervention: Control (nonhormonal contraception)
Number of subjects: 450
Study: 21192797

Group type: EXPERIMENTAL
Intervention: Behavioural sleep intervention (two individual consultations and a follow-up phone call with a trained clinician)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 198
Study: 17350981

Group type: EXPERIMENTAL
Intervention: Dual sensor pacing (TT sensor)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Single sensor pacing (MV sensor)
Number of subjects: 64

Group type: COMPARATOR
Intervention: No rate adaptive pacing
Number of subjects: 64
Study: 15179411

Group type: EXPERIMENTAL
Intervention: Orange juice‐containing serum
Number of subjects: 5

Group type: COMPARATOR
Intervention: Plain orange juice (control)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Serum and purified DHB (in vitro)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Serum and purified DHB (in Caco‐2 cells)
Number of subjects: 5
Study: 11450359

Group type: EXPERIMENTAL
Intervention: Acute ethanol intoxication
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Ethanol withdrawal syndrome
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: All patients
Number of subjects: 66
Study: 9543138

Group type: EXPERIMENTAL
Intervention: GHRP-6 (1 microg/kg, i.v. bolus) with saline
Number of subjects: 9

Group type: COMPARATOR
Intervention: GHRP-6 (1 microg/kg, i.v. bolus) with GHRH Ant (400 microg/kg, i.v.)
Number of subjects: 9
Study: 8092500

Group type: EXPERIMENTAL
Intervention: Halothane
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 20

Group type: COMPARATOR
Intervention: Halothane and Isoflurane
Number of subjects: 20
Study: 3387508

Group type: EXPERIMENTAL
Intervention: Hypnotic suggestion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypnotic suggestion (Experiment 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonhypnotic suggestion (Experiment 2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment (Experiment 2)
Number of subjects: 0
Study: 29049039

Group type: EXPERIMENTAL
Intervention: Blood samples collected immediately after interrupting the medication from peripheral vein and CVC lines.
Number of subjects: 32

Group type: COMPARATOR
Intervention: Blood samples collected 5 minutes after interrupting the infusion from peripheral vein and CVC lines.
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: CVC line used for infusion.
Number of subjects: 32

Group type: COMPARATOR
Intervention: Other lines used for blood collection.
Number of subjects: 32
Study: 27473326

Group type: EXPERIMENTAL
Intervention: Intra-operative cell salvage (CS)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (no intra-operative cell salvage)
Number of subjects: 110
Study: 25649025

Group type: EXPERIMENTAL
Intervention: Febuxostat
Number of subjects: 141

Group type: COMPARATOR
Intervention: Allopurinol
Number of subjects: 141
Study: 23958147

Group type: EXPERIMENTAL
Intervention: Reduced high-dose volume radiation therapy (RHDVRT)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Standard whole-bladder radiation therapy (sRT)
Number of subjects: 219
Study: 20542736

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (500 mg/day orally for 3 consecutive days per month for 3-4 years)
Number of subjects: 341

Group type: COMPARATOR
Intervention: Placebo (identical tablets to methylprednisolone)
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 341

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 341
Study: 17705052

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy (urokinase 12 h, urokinase 2 h, rtPA 50 mg, rtPA 100 mg) in group I
Number of subjects: 520

Group type: EXPERIMENTAL
Intervention: Anticoagulants (heparin, nadroparin) in group II
Number of subjects: 520
Study: 16314023

Group type: EXPERIMENTAL
Intervention: P-50 (3M) resin composite
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Herculite XR (Kerr) resin composite
Number of subjects: 38
Study: 12749247

Group type: EXPERIMENTAL
Intervention: Cimetidine (800 mg/day)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Famotidine (40 mg/day) or Nizatidine (300 mg/day)
Number of subjects: 34

Group type: COMPARATOR
Intervention: No histamine 2 receptor antagonists
Number of subjects: 34
Study: 16335001

Group type: EXPERIMENTAL
Intervention: Canada split influenza virus vaccine (trial group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Homoimported influenza vaccination (control group)
Number of subjects: 0
Study: 10914149

Group type: EXPERIMENTAL
Intervention: Single individual teaching and corrective demonstration session
Number of subjects: 200

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 200
Study: 8834818

Group type: EXPERIMENTAL
Intervention: General anaesthesia (GA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no GA)
Number of subjects: 20
Study: 2282421

Group type: EXPERIMENTAL
Intervention: intermittent treatment (placebo)
Number of subjects: 54

Group type: COMPARATOR
Intervention: continuous treatment (control)
Number of subjects: 54
Study: 7270130

Group type: EXPERIMENTAL
Intervention: Preoperative radiation therapy and surgery
Number of subjects: 354

Group type: COMPARATOR
Intervention: Surgery and postoperative radiation therapy
Number of subjects: 354

Group type: COMPARATOR
Intervention: Surgery and postoperative radiation therapy plus radical radiation therapy (for oral cavity and oropharynx lesions)
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 354
Study: 31568927

Group type: EXPERIMENTAL
Intervention: Biofeedback intervention with personalized inhaler training informed by data from an inhaler compliance assessment device.
Number of subjects: 152

Group type: COMPARATOR
Intervention: Demonstration group received inhaler training by physical demonstration with a placebo inhaler.
Number of subjects: 152

Group type: COMPARATOR
Intervention: Control group received usual care.
Number of subjects: 152
Study: 26752416

Group type: EXPERIMENTAL
Intervention: Topiramate plus MET
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo plus MET
Number of subjects: 66
Study: 26775385

Group type: EXPERIMENTAL
Intervention: Sedoanalgesia (Group S): 1 mg/kg ketamine and 1 mg/kg propofol for induction, followed by infusion of 100-150 μg kg(‐1) min(‐1) propofol and 0.25 mg kg(‐1) h(‐1) ketamine for maintenance
Number of subjects: 60

Group type: COMPARATOR
Intervention: General anesthesia (Group G): 8% sevoflurane by inhalation with 50% nitrous oxide in oxygen for induction, maintained with sevoflurane (2%) and 50% nitrous oxide in oxygen
Number of subjects: 60
Study: 23428307

Group type: EXPERIMENTAL
Intervention: Mobile phone-like RF EMF signals at two different intensities
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham session
Number of subjects: 22
Study: 21334787

Group type: EXPERIMENTAL
Intervention: Telephone care program after hospital discharge
Number of subjects: 604

Group type: COMPARATOR
Intervention: Control group (no telephone care)
Number of subjects: 604
Study: 19526504

Group type: EXPERIMENTAL
Intervention: Planar gradient system
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cylindrical configurations
Number of subjects: 0
Study: 18171494

Group type: EXPERIMENTAL
Intervention: Moderate resistance strength training (RT) at 60% of 1-Repetition Maximum, 3 times per week for 12 weeks
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Detraining period after RT
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 18
Study: 15122753

Group type: EXPERIMENTAL
Intervention: Ribavirin (RBV) and interferon (IFN-alpha)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Dipyridamole (DPD) and Glutathione ester (GSHE)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Diethylmaleate (DEM)
Number of subjects: 34
Study: 11495142

Group type: EXPERIMENTAL
Intervention: Epithelized autogenous masticatory mucosa graft (free gingival graft)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Autogenous predominately connective tissue graft (connective tissue graft)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Acellular dermal matrix
Number of subjects: 45
Study: 9595363

Group type: EXPERIMENTAL
Intervention: Premature labor (39 women)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Premature parturition with no signs of infection (25 women)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Term labor (33 women)
Number of subjects: 97
Study: 7919750

Group type: EXPERIMENTAL
Intervention: Breast feeding
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Maternal education
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Formula supplements
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Cox multiple regression analysis
Number of subjects: 249
Study: 3046481

Group type: EXPERIMENTAL
Intervention: 10 days of rifampin-trimethoprim (RIF-TMP)
Number of subjects: 189

Group type: COMPARATOR
Intervention: 10 days of sulfamethoxazole-trimethoprim (SMX-TMP)
Number of subjects: 189

Group type: COMPARATOR
Intervention: 6 weeks of sulfamethoxazole-trimethoprim (SMX-TMP)
Number of subjects: 189
Study: 31039580

Group type: EXPERIMENTAL
Intervention: Mindfulness training (MT) delivered via smartphone app
Number of subjects: 67

Group type: COMPARATOR
Intervention: Active control (National Cancer Institute’s QuitGuide)
Number of subjects: 67
Study: 28142160

Group type: EXPERIMENTAL
Intervention: Tiopronin 500 mg
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Tiopronin
Number of subjects: 13
Study: 25527243

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 78
Study: 23037619

Group type: COMPARATOR
Intervention: Gradient 0%
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Gradient 2%
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Gradient 7%
Number of subjects: 12
Study: 21210272

Group type: EXPERIMENTAL
Intervention: Clinical barriers (patient education and communication)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Personal barriers (lack of trust and knowledge)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Structural barriers (lack of insurance, facilities, and providers)
Number of subjects: 178
Study: 20695290

Group type: EXPERIMENTAL
Intervention: Child Advocates program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 0
Study: 17234566

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Craniosacral therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acupuncture and craniosacral therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All treatments from one practitioner
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple practitioners
Number of subjects: 0
Study: 15199091

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (MVAC: methotrexate, vinblastine, doxorubicin, and cisplatin)
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Surgical factors (negative margins)
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Surgical factors (>=10 nodes removed)
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Surgical factors (positive margins)
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Surgical factors (fewer than 10 nodes removed)
Number of subjects: 268
Study: 11978332

Group type: EXPERIMENTAL
Intervention: Amodiaquine (10 mg/kg per day for 3 days) plus artesunate (4 mg/kg per day for 3 days)
Number of subjects: 941

Group type: COMPARATOR
Intervention: Amodiaquine (10 mg/kg per day for 3 days) and placebo
Number of subjects: 941
Study: 10176148

Group type: EXPERIMENTAL
Intervention: diacerein 100 mg/day plus standard osteoarthritic therapy for 6 months, followed by a 3-month monitoring period without diacerein
Number of subjects: 207

Group type: COMPARATOR
Intervention: standard therapy alone for the entire 9-month period
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: diacerein plus standard therapy
Number of subjects: 207

Group type: COMPARATOR
Intervention: standard therapy alone
Number of subjects: 207

Group type: COMPARATOR
Intervention: standard therapy group
Number of subjects: 207
Study: 8535807

Group type: EXPERIMENTAL
Intervention: Endoscopic sphincterotomy (ES) and stone removal (group 1)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Surgery alone (group 2)
Number of subjects: 83
Study: 1688616

Group type: EXPERIMENTAL
Intervention: Hydrazine sulfate (60 mg, three times daily)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Hydrazine sulfate
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 631117

Group type: EXPERIMENTAL
Intervention: Stairclimbing
Number of subjects: 52

Group type: COMPARATOR
Intervention: Lift
Number of subjects: 52
Study: 31484539

Group type: EXPERIMENTAL
Intervention: Treatment arm 1 (not specified in detail)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Treatment arm 2 (not specified in detail)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Treatment arm 3 (initial treatment with etanercept and methotrexate)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Treatment to target aimed at inactive disease (all arms)
Number of subjects: 60
Study: 27852444

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 1899

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 1899
Study: 26120902

Group type: EXPERIMENTAL
Intervention: Transcranial ultrasound (2-MHz pulsed wave) for 2 hours
Number of subjects: 824

Group type: COMPARATOR
Intervention: Sham ultrasound (control group)
Number of subjects: 824

Group type: EXPERIMENTAL
Intervention: Transcranial ultrasound and systemic tissue plasminogen activator
Number of subjects: 824

Group type: COMPARATOR
Intervention: Sham ultrasound and systemic tissue plasminogen activator
Number of subjects: 824
Study: 23797999

Group type: EXPERIMENTAL
Intervention: BG-12 (dimethyl fumarate) 240 mg twice daily (BID)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BG-12 (dimethyl fumarate) 240 mg three times daily (TID)
Number of subjects: 0

Group type: COMPARATOR
Intervention: BG-12 (dimethyl fumarate)
Number of subjects: 0